Hb–Vario  The  latest  system  for  diabetes  management  

 

   Mahendra  Paranjape            Sr.  Product  Manager                                  Transasia  Bio-­‐Medicals  Ltd.    

Transasia   Bio-­‐Medicals   Ltd.,   India’s   leading   in-­‐vitro   diagnostic   company   has   been   offering   the   highest  quality  diagnostic  solutions  for  precise  disease  detection  since  more  than  thirty  five  years  across  various  segments.    The  newest  addition  to  the  Transasia  family  is  our  latest  HbA1c  &  HbA2/F-­‐Fully  Automated  Analyzer.      India  has  earned  the  dubious  distinction  of  being  the  ‘Next  Diabetes  Capital  of  the  world.’It  is  estimated  that   millions   of   diabetics   in   India   are   carrying   the   disorder   and   hence   having   complications   of  uncontrolled  diabetes.      HbA1c   is   related  directly   to  risks   for  diabetic  complications  and  hence  used  routinely  to  monitor   long-­‐term  glycemic  control  in  people  with  diabetes  mellitus.    Transasia’s  newly  introduced  Hb-­‐Vario  comprises  HPLC  with  unique  CLE  technology.  The  patented  CLE  technology  enables  complete  elimination  of  labile  glycohemoglobin  thereby  ensuring  accurate  HbA1c  results.   This   product   has   been   developed   in   Europe   after   years   of   research   and   HbA2   is   in   the   final  stages  of  development.    High  Performance   Liquid  Chromatography   (HPLC)   is   still   considered  as   the   ‘gold   standard’  method   for  determination  of  HbA1c.      The  key  features  of  the  instrument  include:    

• The  analyzer  measures  HbA1c  in  approximately  3.5  minutes.  • Sampling  from  multiple  sizes  primary  tubes,  including  micro  capillary  collection  tubes.  • Dual   pump   technology   providing  meticulous   system   control,   resulting   in   exceptional   accuracy  

and  precision  • Unique   CLE   technology   enables   complete   elimination   of   labile   glycohemoglobin   thereby  

ensuring  accurate  HbA1c  results.  •  Capable  of  giving  true  HbA1c  values  in  presence  of  Hb  S,  Hb  C,  HbD,  &Hb  F  • No  interference  of  Hb  F  up  to  10%  • CE,  NGSP-­‐certified  and  traceable  to  IFCC  reference  method.  • Large  color  touch  screen,  in  a  compact  footprint  enables  user  friendly  operation  • Automatic  barcode  identification  of  samples  and  RFID  identification  and  tracking  of  reagents  

• IFCC  traceable  calibrators  and  controls.  • On  board  Quality  control  functions  with  Levey  Jennings  and  statistical  calculations.  • Unlimited  storage  of  calibration,  QC  data  and  chromatograms.